The new software ... modelling, AI, and cloud computing towards improving existing computational methods while exploring new algorithms to address a wide range of drug design challenges.

Its deal with the US-based AI-driven drug design and development company will ... US-based AI firm XtalPi to develop molecular modelling software for drug-like small molecules and Mitsubishi ...

Remarkably, MUNIS achieved accuracy comparable to experimental stability assays, another form of epitope prediction, demonstrating its potential to reduce laboratory burdens and streamline vaccine ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. The digital design realm is ...

an AI model trained on billions of natural protein sequences, to design a functional protein beyond evolutionary constraints. The development is expected to accelerate medical research, drug ...

Abstract: Recent advances in AI applied to high-throughput materials discovery, synthesis, and processing offer a pathway to accelerated breakthroughs and scaled optimization of advanced electronic ...

Oncology researcher Pierce works at Owkin, a Paris-based biotech with a modest goal for AI, he says with a laugh: To double the chances of drug development success from the industry standard of ...

Download the full report. “We believe the principal workload for the future enterprise by 2029 or 2030 is going to be an AI workload — and that will require accelerated infrastructure capable of ...